Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

To the best of our knowledge, the clinical implications of using ribonucleoside reductase subunit M1 (RRM1) in patients who undergo curative resection and adjuvant chemotherapy have not been established. In the present study, the clinical data from 101 consecutive patients who underwent macroscopica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Aoyama, Toru, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5431334/
https://ncbi.nlm.nih.gov/pubmed/28521448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5935
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados